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Abstract
The concept of the Exposome, is a compilation of diseases and one’s lifetime exposure to
chemicals, whether the exposure comes from environmental, dietary, or occupational exposures;
or endogenous chemicals that are formed from normal metabolism, inflammation, oxidative stress,
lipid peroxidation, infections, and other natural metabolic processes such as alteration of the gut
microbiome. In this review, we have focused on the Endogenous Exposome, the DNA damage that
arises from the production of endogenous electrophilic molecules in our cells. It provides
quantitative data on endogenous DNA damage and its relationship to mutagenesis, with emphasis
on when exogenous chemical exposures that produce identical DNA adducts to those arising from
normal metabolism cause significant increases in total identical DNA adducts. We have utilized
stable isotope labeled chemical exposures of animals and cells, so that accurate relationships
between endogenous and exogenous exposures can be determined. Advances in mass
spectrometry have vastly increased both the sensitivity and accuracy of such studies. Furthermore,
we have clear evidence of which sources of exposure drive low dose biology that results in
mutations and disease. These data provide much needed information to impact quantitative risk
assessments, in the hope of moving towards the use of science, rather than default assumptions.
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In 2005, Chris Wild brought forward the concept of the “Exposome” [1]. He suggested that
together with genomics, metabolomics, proteomics, and transcriptomics, we need to also
understand relationships between life-time exposures to chemicals and disease. This concept
was further explored several years later by Lijoy and Rappaport [2] and by Chris Wild [3],
who pointed out that the assessment of exposures should not be restricted to chemicals
entering the body from air, water, food, smoking, etc., but should also include internally
generated toxicants produced by the gut flora, inflammation, oxidative stress, lipid
peroxidation, infections, and other natural biological processes. In other words, we must
focus upon the ‘internal chemical environment’ arising from all exposures to bioactive
chemicals from within and outside the body.
This review will focus on recent advances in our understanding of endogenous DNA
damage arising from the internal environment, and how it compares with external exposures.
Advances in analytical methods have vastly changed our ability to accurately measure
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biomarkers such as DNA adducts and protein adducts over the past two decades. When this
is coupled with exposure to stable isotope labeled chemicals that cause identical DNA
damage, we now can accurately compare the exposures that arise endogenously, with those
coming from environmental, occupational and life style chemical exposures. This has
important implications for understanding exposure responses, such as causality of mutations,
cancer, disease and aging. Likewise, it begins to explain why mutations do not extrapolate to
zero when studied at very low exposures. Rather, they often reach thresholds that appear to
be driven by the Endogenous Exposome. The field of low dose mutagenesis, rather than high
dose studies for hazard identification, has been grossly understudied, but is of great
importance for the advancement of science-based risk assessment.
Research related to endogenous DNA damage and its relationship to a variety of chemical
exposures has been a major focus of our laboratory for the past two decades. This review
will cover research on abasic sites, oxidative DNA damage and several known human
carcinogens that form exogenous adducts identical to endogenous DNA adducts, what the
exposure-response relationships are for identical endogenous and exogenous DNA damage,
and how this knowledge of the Endogenous Exposome helps us understand exposure-
responses for mutations and disease, as well as informing science-based risk assessment.
Apurinic/apryrimidinic sites
Apurinic/apryrimidinic (AP) sites are known to be one of the most prevalent types of
endogenous DNA lesions (Table 1.). Endogenous AP sites in cellular DNA are partly
derived from spontaneous depurination and depyrimidination of normal and unstable
modified bases (e.g., N7-methylguanine (N7-meG) and N3-methyladenine (N3-meA)). In
1973, the rate of spontaneous AP site formation was first estimated to be 10,000 sites/
cell/day using the depurination rate of DNA at 70°C and physical chemistry [4].
Twenty five years later, we directly demonstrated that AP sites are generated at 1.54 AP
sites/l06 nucleotides/day (~9,000 AP sites/cell/day) at 37°C and pH 7.4 using aldehyde
reactive probe [5]. In addition to spontaneous hydrolytic base loss, AP sites are also
generated by the base excision repair pathway. An AP site serves as an intermediate DNA
lesion during the repair of several modified bases, [6–8]. Our accumulated results indicate
that the steady-state level of AP sites is approximately 30,000 lesions per genome in
mammalian cells and tissues [9]. It is important to point out that these endogenous AP sites
are likely oxidized deoxyribose [10]. Endogenous hydrogen peroxide, one of the major
endogenous reactive oxygen species, generates hydroxyl radicals though the Fenton reaction
with ferrous (Fe2+) ions loosely attached to the N7 position of guanine and preferentially
oxidizing the adjacent deoxyribose to generate various oxidized deoxyriboses, resulting in
oxidized AP sites [11–13],. Since deoxyribose lesions are hard to quantitate with high
sensitivity and specificity, a steady-state level of oxidized deoxyribose and their biological
importance are largely unknown even though they are among the most abundant endogenous
DNA lesion in living organisms. The regular AP sites, derived from spontaneous
depurination and DNA glycosylase reactions, are cytotoxic through DNA replication
blockage. In addition, they are mutagenic through translesion DNA synthesis. Previous
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articles have extensively reported mutational potential and spectrums of AP sites in cells by
transfection of exogenous DNA harboring AP sites.
We utilized an endogenous gene to better understand mutagenicity of AP sites in vertebrate
cells under more physiological conditions. DT40 cells (chicken B cells) that naturally
express O6-alkylguanine DNA alkyltransferase (MGMT) were continuously exposed to very
low doses of methylmethane sulfonate (MMS). These conditions allowed cells to repair
mutagenic O6-methy-2′-dexoyguanosine (O6-mdG) before DNA replication and generate
AP site-specific mutations [14]. We found a hockey-stick dose response curve with steady-
state levels of mutations. Approximately half of the mutations induced by the low
concentrations of MMS were transversion mutations at mainly adenine positions and the
remaining half were deletions or insertions. These results suggest that N3-meA-derived AP
sites likely cause transversion mutations and possibly deletion and insertion mutations
through N-methylpurine-DNA glycosylase function, or via spontaneous depurination. While
AP sites in genomic DNA sounds like unwelcome DNA lesions, some of the endogenous
AP sites are essential for normal biological function such as cytosine methylation.
Activation-induced deaminase (AID) initiates immunoglobulin diversity through
deamination of cytosine to uracil [15, 16]. The uracil is excised by uracil-DNA glycosylase
to generate AP sites, which cause mutations by translesion DNA synthesis and initiate
recombination in immunoglobin genes [7]. In contrast to the beneficial property of AP sites,
constitutive expression of AID (e.g., under chronic inflammation) causes an increase in
global accumulation of uracil, 5-hydroxymethyluracil and possibly AP sites in non-
immunogloblin genes, leading to mutations and cancers [7, 17, 18]. In summary, tightly
controlled AP site formation and repair are beneficial for normal biological functions,
however, imbalanced repair of AP sites leads to an increase in mutations above the threshold
level.
Reactive Oxygen Species
Endogenous DNA adducts have been identified in cellular DNA from cultured cells, tissues
of animals and humans. As shown in Table 1, a majority of endogenous DNA damage
appears to be derived from oxidative stress [9]. Apurinic/apyrimidinic (AP) sites are the
most abundant, spontaneous DNA lesions. One of the characteristics of AP sites suggests
that they may be oxidized deoxyribose and exist in cells under normal physiological
conditions [9]. DNA single strand breaks (SSBs), which occur adjacent to oxidized AP sites
through DNA repair mechanisms, or by spontaneous cleavage, should therefore be among
the most profuse endogenous DNA lesions. However, due to technical difficulties in
quantitating SSBs with high sensitivity and specificity, accurate steady-state levels are not
well characterized to date. The next three most abundant endogenous DNA lesions are N7-
(2-Hydroxyethyl)G, N7-(2-Oxoethyl)G, and 8-oxodG [9]. All three of these base adducts are
caused by oxidative DNA damage due to either lipid peroxidation products or reactive
oxygen species (ROS). Among various endogenous ROS, hydrogen peroxide (H2O2) is the
most diffusible and plentiful, and are mainly produced by mitochondria under physiological
conditions. In addition to mitochondria-derived H2O2, oxidative demethylation by histone
demethylase (e.g., LSD1 and LSD2) produces H2O2 and formaldehyde, two major sources
of endogenous DNA damage. These two reactive endogenous molecules are produced in
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close proximity to genomic DNA, suggesting the H2O2 resulting from oxidative
demethylation of histones could more efficiently damage DNA than mitochondria-derived
H2O2. In fact, it has been reported that when LSD1-mediated demethylation occurred,
oxidative DNA lesions were increased [19, 20]. Surprisingly, data have demonstrated that
LSD1-mediated local oxidative DNA damage and its repair mechanisms work as a driving
force in transcription initiation [19, 20]. This suggests that oxidative DNA damage could be
beneficial for certain biological functions.
Previously, our lab demonstrated that the formation of single strand breaks, AP sites, and 8-
oxo-dG followed a biphasic or polynomial dose response in H2O2-treated HeLa cells at
concentrations ranging from 60 to 20,000 uM [21, 22]. To better understand the association
between very low amounts of H2O2-induced oxidative base damage (Biomarkers of
Exposure) and mutation events (Biomarkers of Effect), we conducted thymidine kinase (tk)
gene mutation assays and 8-oxodG assays in human lymphoblastoid (TK6) cells exposed to
H2O2 at concentrations ranging from 1 to 56.6 uM. As with MNU [23], H2O2 induced a
hockey-stick dose response indicative of a threshold (Figure 1). We also found that H2O2
induces 8-oxodG with a hockey-stick dose response (unpublished results). The results
indicate that H2O2 increases the frequency of mutations when oxidative DNA lesions are
increased above spontaneous oxidative DNA damage. This implies that spontaneous
mutations could be derived from oxidative DNA lesions.
In addition to direct oxidative DNA damage, ROS indirectly induces uracil and 5-
hydroxymethyluracil from cytosine and 5-hydroxymethylcytosine (down-stream products of
5-methylcytosine) by enzymatic deamination though activation-induced deaminase (AID)
function. AID-mediated deamination was observed under chronic oxidative stress, including
chronic inflammation caused by bacterial/viral infection [17]. This suggests that uracil and
5-hydroxymethyluracil should be recognized as oxidative stress-associated DNA lesions.
Vinyl Chloride
Vinyl chloride (VC) is a widely used chemical that was shown in the 1970’s to induce
hepatic angiosarcomas in workers. Human epidemiology and animal carcinogenicity studies
lead to its classification as a human and rodent carcinogen [24–29]. While VC is used in
industry to produce polyvinyl chloride (PVC) production, it also is present in tobacco
smoke, and is found at Superfund sites due to microbial dechlorination of perchloroethylene
and trichloroethylene [30–34]. VC requires metabolic activation by CYP450 2E1 to produce
chloroethylene oxide (CEO), which covalently binds to DNA to induce four DNA adducts,
while the secondary metabolite chloroacetaldehyde, alkylates primarily proteins [35–38].
The major DNA adduct [39] that is formed from the reaction between CEO and DNA is 7-
(2-oxoethyl)guanine (7-OEG). This adduct lacks miscoding properties and it is removed
from DNA primarily by chemical depurination. The exocyclic DNA adducts that are
induced by VC, such as N2,3-ethenoguanine (εG), 1-N6-ethenodeoxyadenosine (εdA), and
3,N4-ethenodeoxycytosine (εdC), have been studied in greater detail due to their
promutagenic activity during DNA synthesis [40–42].
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Previously, exocyclic endogenous VC DNA adducts [43–49] and more recently 7-OEG [50]
have been detected in tissues of unexposed rats and/or humans, and have been shown to
arise from lipid peroxidation and oxidative stress [51–54]. Several studies demonstrated the
endogenous εdA and εdC formation in unexposed rodents by 32P-postlabeling [55]. While
control liver DNA had 0.4–5.8 εdA/109dA and 0.6–40 εdC/109dC, lung and kidney had 1–2
εdA/108dA and 5–12 εdC/108dC; 2.5–3.5 εdA/108dA and 8–12 εdC/108dC, respectively.
The t1/2 of εdA was reported to be 24 h by Ham et al. [56], while 0.8 εdA/108dA was
detected in control and Aag null mouse liver and 0.1 εdC/108dC in control and 0.7 εdC/
108dC in Aag knockout mouse lung. In our laboratory, a new nano-UPLC-MS/MS method
was developed to measure endogenous and exogenous εdA formation in rats exposed to1100
ppm [13C2]-VC for 5 days (6 hr/day) (Gao, unpublished data). While endogenous εdA was
4.9±0.6/108dA, [13C2]εdA was 5.1±0.6/108dA in [13C2]-VC exposed rat liver following
exposure (Table 2).
In vivo formation of εG has been measured by GC-NICI-MS [57–60], immunoaffinity
coupled-GC/HRMS [45, 48, 49, 61] and LC-MS/MS [62]. Fedtke et al. [59] reported the
formation of εG that could not differentiate between endogenous and exogenous sources in
rats exposed to 600 ppm VC for 5 days. While the concentration of εG was found to be the
highest in liver, followed by the kidney and lung, the persistence was ~30 days. Being able
to distinguish between endogenous and exogenous DNA adducts in the same animals were
demonstrated for the first time by Morinello et al., using stable isotope labeled VC to
determine the molecular dose of εG in rats exposed to 0, 10, 100 and 1100 ppm [13C2]-VC
for one or four weeks [45, 48, 49, 61]. Rapid increases of [13C2]-εG adducts in hepatocyte
liver DNA was reported between 10 and 100 ppm exposures, followed by a lower slope in
adduct formation at 1100 ppm, thought to be the result of partial saturation of metabolic
activation of VC. While endogenous εG was present in liver and brain, exogenous εG was
detected in liver only. Similar results were reported by Mutlu et al. [62] for the formation of
endogenous and exogenous εG in liver DNA (4.1±2.8 endogenous εG/108G and 18.9±4.9
[13C2]-εG/108G). In contrast, both endogenous 7-OEG and [13C2]-7-OEG were detected in
several organs, including liver and brain in rats exposed to 1100 ppm [13C2]-VC [50] This
suggests that not only liver, but the other organs are able to form low amounts of CEO,
which results in lower [13C2]-7-OEG adduct formation, it is believed that VC is metabolized
in each organ by CYP450, rather than arising via the circulation of higher liver-based CEO
formation in the body.
When identical endogenous and exogenous DNA adducts are formed, the only way to derive
accurate t1/2 data is to conduct stable isotope exposures so that exogenously formed adducts
have a higher mass than the corresponding endogenous adducts. In the earlier studies on VC
DNA adducts without the use of stable isotope exposures, clearly determining how many
DNA adducts came from normal cellular processes and how many were from the stable
isotope exposures was not possible. This is well demonstrated in Table 2. The number of
endogenous adducts do not change with time, as they are continuously formed and are
thought to be at steady-state concentrations. To determine t1/2 data, one must focus on the
stable isotope labeled adducts that came from the exposures. For VC adducts, one can see
that εdA has very rapid repair, with no labeled adducts being detectable after 2 weeks post
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exposure, the shortest time post exposure in this study. [13C2]-7-OEG had a t1/2 of 4 days,
while [13C2]-N2,3-εG had a t1/2 of 150 days [40, 62]. This is not thought to be active DNA
repair. Rather, it most likely represents loss due to cell death and cell replication.
Ethylene/Ethylene Oxide
IARC reviewed the epidemiology of occupational exposure of humans and considered that
ethylene oxide was Carcinogenic for Humans and that there was sufficient evidence of
carcinogenicity in experimental animals [63] While not yet studied with stable isotope
exposures, ethylene oxide (EO) is also formed endogenously. The endogenous production of
ethylene results from oxidative stress [64] and from gut microflora [65]. Endogenous
ethylene circulates in the blood and is metabolized to EO in the liver [66], which also
circulates in the body. Endogenous EO forms N7-(2-hydroxyethyl)guanine adducts as
shown in Table 1. Endogenous EO is also exhaled in human breath 24/7. Thus, we all have
endogenous exposure to EO, a second known human carcinogen. Hprt mutations have also
shown nonlinear responses following inhalation exposure of rats to ethylene oxide [67].
Isoprene
Isoprene is the predominant hydrocarbon in the environment, being formed by both
deciduous and conifer trees, as well as plants, with 10–100 ppb carbon being present in
forest canopies. It also formed endogenously in humans and animals. Human production of
isoprene has been calculated to be 0.15 μmol/kg/hr, resulting in blood concentrations
between 15 and 70 nmol/L and breath concentrations in the range of 10–30 nmol/L, with 2–
4 mg exhaled per day per individual [68]. Thus, all humans have relatively high endogenous
exposure to isoprene daily. Isoprene is metabolized to two epoxides and a diepoxide that are
genotoxic. These can form DNA adducts [69, 70]. Isoprene is carcinogenic in mice and rats,
but has not been evaluated in human epidemiology studies [71]. To date, no studies of
isoprene DNA adducts in animals exposed to stable isotope-labeled isoprene have been
conducted, for comparisons for endogenous and exogenous formation.
Endogenous and Exogenous DNA Adducts from Alkylating Agents
DNA alkylation can cause stalled replication, mispairing and DNA strand breaks ultimately
leading to mutations or cell death [72, 73]. While these modes of DNA damage are known
to be prominent key events in carcinogenesis, it has also been exploited as the anticancer
therapy for a long time [73]. Alkylating agents exert their mutagenic and genotoxic effects
by forming adducts with the N- and O-atoms in DNA bases [74]. The different proportions
of adducts at oxygen versus nitrogen in DNA depend upon the nature of the reactive moiety
[75]. Compounds such as methylmethane sulfonate (MMS) that have a high Swain Scott
constant (s value) target highly nucleophilic centers within DNA (e.g., N7-G, N3-A)
yielding N7-mG and N3-mA [76]. Low s value alkylating agents such as methylnitrosourea
(MNU) alkylate O atoms (e.g., O6-mdG) more efficiently than those with high s values.
Though the alkylations at O atoms are formed at a much lower rate compared to N-
alkylations, the resulting O6-mdG adducts are highly promutagenic and can result in
mismatches during DNA replication leading to mutations [77]. Alkylation at the O6 position
of guanine and O2 and O4 positions of thymine induces GC to AT, AT to GC and AT to TA
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mutations, respectively [78]. Formation of DNA alkyl adducts may result from both
endogenous as well as environmental alkylating agents. The properties of some alkylating
agents (e.g. MMS and MNU) that react directly with DNA and trigger highly mutagenic
effects makes them a popular model in laboratories for low-dose risk assessment and other
mutagecity studies [79].
The major source of endogenous methylation is S-adenosylmethionine (SAM) which is a
key compound in transmethylation, aminopropylation and transsulfuration metabolic
pathways within cells [80]. It can act as a weak DNA methylating agent by forming adducts
with DNA in a non-enzymatic manner [80]. The methylation pattern of SAM mimics MMS
and acts by SN2 reaction, therefore, yielding more N7 and N3 adducts than the O6 adducts.
The ability of SAM to act as a methyl donor in a nonenzymatic reaction could contribute to
the background mutation rate [80]. Endogenous DNA alkylations are considered to be a
major contributor to the total background levels of DNA adducts (Table 1) [81].
Endogenous methyl adducts reflect part of the ever-present carcinogenic load in biological
systems. The use of highly sensitive LC-MS/MS and isotope labeled compounds provides a
tool to accurately identify and differentiate the origins of exogenous and endogenous DNA
adducts. Using this sensitive approach, an earlier study from our group reported for the first
time, minor methyl adducts at N2-dG and N6-dA positions. Both showed a linear dose
response with N2-methyl-dG having several-fold higher amounts than N6-methyldA.
However, N2-methyl-dG and N6-methyl-dA were found to be minor alkylation products
compared to the N7-mG and O6-mdG [82].
For alkyl-DNA adducts, O6-mdG is considered to be the main contributor to point
mutations. However, their low number and highly efficient repair mechanism makes their
detection and quantification at low doses quite challenging [83, 84]. In a study by Brink et
al., the O6-mdG amounts in rat liver DNA were found below the limit of quantitation, but
above the limit of detection (3.7 adducts per 109 nucleotides) [83]. Georgiadis et al. were
able to detect O6-mdG in 70% of maternal and 50% of cord blood buffy coat samples at
mean levels of 0.65 and 0.38 adducts/108 nucleotides, respectively, by using a new ELISA
type assay [85]. The exquisite sensitivity of stable isotope nano-UPLC-MS/MS adduct
detection offers opportunities for the development of biomarkers of exposure. Whereas
biomarkers of exposure are expected to be linear down to zero unless removed by DNA
repair, biomarkers of effect (e.g. mutations) can only be interpolated back to the
spontaneous or background numbers of mutations. Recently, we conducted studies to
compare the dose response relationships of MNU-induced DNA adducts with previously
published mutation frequencies [23, 79] at low exposures. When identical endogenous DNA
adducts are formed, the only way to determine the molecular dose of the exogenous DNA
adducts is to utilize stable isotope-labeled chemicals and ultra-sensitive mass spectrometry.
We utilized [D3]-MNU, so that adducts formed by the exposure were three mass units higher
than the endogenous DNA adducts. This permitted accurate quantitation of both N7-mG and
O6-mdG at attomol concentrations. The lowest two doses of [D3]-MNU were measureable,
but did not significantly increase the total number of endogenous and exogenous O6-mdG.
These molecular doses of O6-mdG were consistent with the previous doses that resulted in a
threshold for point mutation studies. This demonstrated that very low amounts of exogenous
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O6-mdG did not significantly increase the total O6-mdG until ~10-fold higher doses of [D3]-
MNU were used for exposures.
When exogenous and endogenous N7-mG were measured in the same cells, the endogenous
amounts of N7-mG were ~20-fold greater than that formed by the [D3]-MNU at the lower
end of exposure. Thus, much higher numbers of endogenous N7-mG adducts were present
than were O6-mdG adducts. The molecular dose of the major DNA adducts, N7-mG and O6-
medG, was quantified, over the same dose range as studied by Thomas et al. [23]. The
exogenous DNA adducts were linear over the entire dose response and intersected with
identical endogenous adducts (Figure 2) [86]. In contrast to DNA adducts, Thomas et al.,
found non-linear responses in point mutations, with a no-observed genotoxic effect level
(NOGEL) of approximately 0.075uM and the lowest observed genotoxic effect level
(LOGEL) of 0.1uM [23]. Combining these data, it can be concluded that only O6-medG
adducts of ≥ 1.8/108 dG were effective in producing significant increases in mutations in
AHH-1 cells. In contrast, at very low exposures, the biology that results in mutagenesis is
driven by endogenous DNA damage, including identical endogenous DNA adducts.
It is also likely that DNA repair represents yet another mechanism for non-linear threshold
response curves for alkylating agents [23, 87]. For example, EMS administered to mice in a
single high dose caused mutations, but when the same total dose of EMS was given to the
mice over 28 days, no increase in mutations was present [88]. Acrylamide induces increases
in micronuclei at high doses, but not at low doses administered to mice [89]. Another recent
example of this is the paper on radiation from the Engelwald laboratory at MIT, where a
single high exposure to x-irradiation caused increased micronuclei, but the same total dose
administered over 4 weeks did not induce any increase in micronuclei [90].
Formaldehyde
Formaldehyde is classified as a known human and animal carcinogen according to IARC
[91], following inhalation exposure. Formaldehyde exposure from occupational and
environmental sources is very common. Formaldehyde can covalently bind to DNA,
proteins and other cellular nucleophiles, forming formaldehyde derived DNA adducts [92–
96], DNA-DNA crosslinks, DNA-protein crosslinks (DPCs) [97–103], and DNA-glutathione
adducts [104] that, if not repaired or hydrolyzed, can lead to mutagenesis and
carcinogenesis.
What is less understood is that formaldehyde is formed endogenously in all living cells [9].
The endogenous presence of formaldehyde and the high concentrations normally found in
cells also result in the formation of identical DNA adducts and crosslinks to those formed by
exogenous exposure. Because there is endogenous formaldehyde resulting in the same DNA
damage, it is challenging to develop biomarkers of formaldehyde exposure and to
understand its toxicity. Our laboratory has employed stable isotope-labeled formaldehyde
exposures to afford the ability to differentiate between formaldehyde molecules of
endogenous and inhaled exogenous origin. Exposure to stable isotope labeled [13CD2]-
formaldehyde and the associated endogenous formaldehyde can readily be measured using
nano-ultra performance liquid chromatography-tandem mass spectrometry (nano-UPLC-
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MS-MS, limit of detection reaches 1.25 amol) [82, 105–108]. Because the hydroxymethyl
DNA adducts of formaldehyde are chemically unstable, they must be reduced to a methyl
adduct using cyanoborohydride prior to analysis. This approach is shown in Figure 3.
The primary genotoxic effects of formaldehyde are thought to result from the formation of
DPCs. Increased DPCs were detected in nasal mucosa of rats exposed to formaldehyde by
inhalation at concentrations greater than 6 ppm [109]. However, there were no detectable
DPCs in the bone marrow of normal rats exposed to formaldehyde at concentrations as high
as 15 ppm [110]. Similarly, DPCs were found in the nasal turbinates and anterior lateral
wall/septum of non-human primates (NHPs) following exposure to as little as 0.7 ppm
formaldehyde, while no DPCs were detected in the bone marrow at concentrations as high as
6 ppm [111]. Further studies indicated that protein adducts and DPCs were not detected in
the bone marrow of rats exposed to formaldehyde at concentrations as high as 10 ppm [112],
even when the degradation of formaldehyde was inhibited by glutathione depletion [98].
However, rapid decreases in formaldehyde induced DPCs were observed in cell culture
models [113–115], but no accumulation of DPCs were observed in rats after multiple days
of exposure [116]. Furthermore, evidence indicates that a major portion of formaldehyde
induced DPCs were lost from lymphocytes through spontaneous hydrolysis, rather than
being actively repaired [101].
The inability to distinguish between exogenous and endogenous formaldehyde associated
DNA damage is a clear short coming for all previous studies on formaldehyde-induced DPC
formation measured following formaldehyde exposures. This includes the potassium-SDS
precipitation and chloroform/iso-amyl alcohol/phenol extraction [109, 117], both of which
are not only unable to distinguish between endogenous and exogenous formaldehyde, but
also cannot differentiate formaldehyde DPCs from DPCs induced by other cross-linking
endogenous or exogenous chemicals.
The structures of formaldehyde-induced DNA adducts in vitro have been known for decades
[93–96] and include the unstable DNA adducts N2-hydroxymethyl-deoxyguanosine (N2-
HOMe-dG), N6-hydroxymethyl-deoxyadenosine (N6-HOMe-dA), and N4-hydroxymethyl-
deoxycytosine (N4-HOMe-dC) [118–120]. N2-HOMe-dG is the main DNA mono-adduct
induced by inhaled formaldehyde, which together with DNA protein crosslinks and toxicity-
induced cell proliferation are thought to play important roles in mutagenesis and
carcinogenesis. However, similar numbers of endogenous N2-HOMe-dG and N6-HOMe-dA
are present in most tissues [105].
In a study of formaldehyde DPC formed between deoxyribose nucleosides and amino acids
or their oligos, we found that dG-lysine was the most formed cross-link, but that it very
rapidly (2–5 minutes) underwent hydrolysis [121]. The second most formed cross-link was
dG-cysteine. This cross-link was also shown to be the most stable. We have now evaluated
the dG-cysteine, dG-glutathione, and a peptide from MGMT that also forms a dG-cysteine
cross-link. When these were analyzed for hydrolytic degradation, we found that N2-HOMe-
dG was the dominant product (data unpublished). This demonstrates that N2-HOMe-dG
represents an excellent biomarker for both spontaneous DPC hydrolysis and direct adduction
of inhaled formaldehyde to DNA.
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In studies using inhalation exposure to [13CD3]-formaldehyde, we clearly demonstrated that
exposures of labeled [13CD2]-formaldehyde induced [13CD2]-N2-HOMe-dG adducts in
nasal epithelium of rats and monkeys [105–107]; however, these adducts were not detected
in tissues distant to the site of contact, including lung, liver, spleen, mononuclear white
blood cells, or bone marrow [105]. In contrast, endogenous N2-HOMe-dG and N6-HOMe-
dA adducts were readily detected in all tissues examined [105]. When [13CD4]-methanol
was administered to rats, [13CD4]-N2-HOMe-dG and [13CD4]-N6-HOMe-dA adducts were
formed in kidney and bone marrow [108], suggesting that the N6-HOMe-dA adducts are
only formed when methanol is metabolized to formaldehyde within a cell.
Our most recent study that exposed rats to 2 ppm [13CD3]-formaldehyde for up to 28
consecutive days further demonstrated [13CD2]-N2-HOMe-dG accumulation, with 28 days
being the approximate time to reach steady-state concentration, and the t1/2 for the repair/
loss of [13CD2]-N2-HOMe-dG in vivo being ~202 hrs. As with our previous studies [105–
107], endogenous formaldehyde-induced N2-HOMe-dG adducts were observed in all tissues
analyzed; however, exogenous formaldehyde-induced [13CD2]-N2-HOMe-dG adducts were
only detected in the nasal respiratory epithelium DNA of rats exposed to [13CD2]-
formaldehyde by inhalation, providing compelling evidence that inhaled formaldehyde does
not reach tissues distant to the sites of initial contact in an active form. A nonhuman primate
study utilizing up to 6 ppm [13CD3]-formaldehyde exposures for two 6hr/day exposures had
the ability to find one [13CD3]-N2-HOMe-dG adduct in 10 billion unmodified dG, but no
exogenous adducts were found in bone marrow [107]. A similar sensitivity was used to
evaluate mononuclear white blood cells in the 28-day rat study, but none were found. This
raises important questions regarding how inhaled formaldehyde could cause leukemia [122].
By conducting studies at durations ranging from a single 6 hr exposure, to 5 days (6hr/day),
and up to 28 consecutive days (6hr/day), it was clear that exogenous N2-HOMe-dG adducts
had not reached steady-state concentrations, while endogenous N2-HOMe-dG adducts were
at steady-state due to continuous intracellular formation through normal metabolic
pathways. When the National Research Council reviewed the 2010 EPA IRIS Cancer Risk
Assessment, they pointed out that understanding what exposures to formaldehyde increased
the intracellular amounts of total formaldehyde above the endogenous represented critical
data for risk assessment [123].
In summary, the use of stable isotope formaldehyde exposures has provided new insight and
tools for science-based risk assessment. The data generated in these studies provide pivotal
information for understand the toxicity and carcinogenicity of formaldehyde, as well as the
biological plausibility of leukemia induction following inhalation exposure to environmental
formaldehyde. The NRC Review of the Environmental Protection Agency’s Draft IRIS
Assessment of Formaldehyde in 2011, strongly suggested that such data be incorporated into
a revised risk assessment [123].
Acetaldehyde
Acetaldehyde is a highly reactive 2-carbon aldehyde that is a ubiquitous environmental
pollutant with a variety of potential human exposures ranging from occupational activities,
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consumer products, lifestyle choices (food/alcohol/cigarette consumption), and
environmental sources [124]. Acetaldehyde is listed as reasonably anticipated to be a human
carcinogen by the National Toxicology Program and as a human carcinogen from the
metabolism of ethanol by the International Agency for Research on Cancer [124, 125].
Acetaldehyde is also a metabolite of vinyl acetate, a common industrial chemical used in the
manufacture of a variety of consumer and industrial applications. Acetaldehyde is
endogenously produced as a by-product of cellular respiration and metabolism [126–128].
Complicating the risks associated with acetaldehyde exposure is that the primary route of
detoxification of acetaldehyde to acetate is via a well characterized polymorphic enzyme,
aldehyde dehydrogenase 2 (ALDH2) metabolism of acetaldehyde to acetate [129].
Acetaldehyde is a direct, DNA reactive mutagen causing a number of genotoxic effects
including DNA adducts, DPC, DNA-protein crosslinks, DNA-DNA crosslinks, single strand
and double strand breaks, micronucleus formation, mutations, and sister chromatid exchange
(reviewed in [130]). The two primary DNA adducts formed and measured as biomarkers of
exposure are N2-ethylidene-dG and 1,N2-propano-dG. The N2-ethylidene-dG adduct is
formed following the direct attack of acetaldehyde at the N2 position of 2′-deoxyguanosine.
In contrast, the 1,N2-propano-dG adducts can arise from either the reaction of
crotonaldehyde, or by two molecules of acetaldehyde catalyzed by the amines of histones, or
amino acids found in the nucleus [131, 132]. Similar to the N2-OHMe-dG adduct of
formaldehyde, N2-ethylidene-dG is unstable (t1/2 = 20 min) at the nucleoside level and
requires reduction with a strong reducing agent to the more stable N2-ethyl-dG for analysis
[133]. Site directed mutagenesis studies have shown that the stable N2-ethyl-dG adducts are
weakly mutagenic, while 1,N2-propano-dG adducts have a higher mutagenic potential [134,
135]. The 1,N2-propano-dG adduct can exist in either the ring opened or closed positions,
from which the ring opened form may react to form either DNA-DNA or DNA-protein
crosslinks (reviewed by [136]).
The N2-ethylidene-dG and 1,N2-propano-dG adducts are the most commonly measured
biomarkers of exposure to acetaldehyde. Recent studies [132, 133] in cell culture using
stable isotope exposures of [13C2]-acetaldehyde have revealed that both endogenous and
exogenous lesions can be formed. Our recent data [133] reporting N2-ethylidene-dG adduct
formation in TK6 cells exposed to a [13C2]-acetaldehyde concentration range ≥4.5 orders of
magnitude illustrates several key points. Using the stable isotope approach, the endogenous
adducts remained relatively constant across the dose range (~2–3 adducts/107 dG), with
similar results to what has been observed in our [13CD2]-formaldehyde [105–107] and [D3]-
MNU studies. At low exogenous exposure conditions (≤10 μM), the amount of endogenous
N2-ethylidine-dG adducts dominates over much smaller numbers of exogenous adducts
(Figure 4). At high exposure conditions (≥250 μM), exogenous adducts dominated over
endogenous adducts. The stable isotope exposures allowed for ~50x difference in the lowest
concentration (1 μM), with observable formation of exogenous DNA adducts over the sum
(endogenous + exogenous) of the adducts at 50 μM, as would have been observed using
unlabeled acetaldehyde. Importantly, the exogenous adducts had a linear dose-response
across the dose range, while the sum of the adducts showed a non-linear response that
demonstrates a threshold in DNA adduct formation at 50 μM and below. This nonlinearity
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was also observed for micronucleus formation rates and cell survival, with statistically
significant increases over background occurring at 1000 μM [133]. A more in-depth study
investigating the chromosomal and gene level effects of acetaldehyde using 4 and 24 hour
exposures showed a non-linear dose-response for micronucleus formation and the induction
of mutations at the thymidine kinase (TK −/−) loci between 50 and 100 μM in TK6 cells
[137].
These studies utilizing stable isotopes and large exposure ranges support the hypothesis that
that endogenously produced reactive species, including acetaldehyde, formaldehyde and
lipid peroxidation are always present, and constitute a majority of the observed background
DNA damage following low exposures to these compounds.
Discussion
As shown in this review, recent advances in analytical chemistry have greatly increased the
accuracy, sensitivity and identification of endogenous DNA damage. In addition, new
sources and forms of endogenous DNA damage are being identified that arise from
oxidative stress and inflammation. As these new sources and types of damage are
discovered, new associations with mutations and diseases are becoming known. Thus, the
role of the Endogenous Exposome is rapidly gaining broader acceptance. When such DNA
damage is coupled with the use of stable isotope exposures, highly informative data can be
collected that place experimental, life style, environmental, occupational and medical
exposures in perspective with identical endogenous DNA damage. Thus, Chris Wild’s
Exposome concept has been shown to be complex, but doable. As such, the effects of both
endogenous and exogenous exposures can be placed in better perspective [1, 3]. It is likely
that evaluating the Exogenous Exposome over a life-time will be even more difficult than
similar studies on the Endogenous Exposome.
A recent study using the Rag2−/− mouse model together with Helicobacter hepaticus
demonstrated that in the absence of the innate immune system, hypochlorous acid formed by
myeloperoxidase from neutrophils formed large amounts of 5-chlorocytosine that was
strongly associated with inflammatory bowel disease [138]. Etheno and other exocyclic
DNA adducts also have been examined in animal and human studies by Bartsch and
colleagues. These studies range from age-dependent increases in etheno DNA adducts in
liver and brain of OXYS rats compared to age-matched Wistar rats [139] Likewise, iron and
copper accumulation in the liver has been associated with increased numbers of exocyclic
DNA adducts, as has inflammation and alcoholism [60, 140–142]. As additional research on
inflammation and cancer is done, it is likely that additional endogenous forms of DNA
damage will be shown to play roles in disease. Furthermore, improved chemical
identification and quantitation of newly discovered forms of endogenous DNA damage are
highly likely. Thus, the Endogenous Exposome is expected to grow as sources of new DNA
damaging electrophiles are identified and their consequences known.
Genetically altered cell lines, such as the DT40 cells that have single gene knock outs,
permit identification of critical pathways for DNA repair [156]. Such studies have already
resulted in the development of animal models that demonstrate the importance of the
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Endogenous Exposome. For example, it has become more evident that endogenous
aldehydes play a large role in human diseases. While the importance of ALDH2 in the
clearance of acetaldehyde has been well understood for many years, Ridpath et al.,
demonstrated that FANCD2 was an essential gene for DT40 cells to survive exposures to
formaldehyde and to acetaldehyde [143]. The interplay of these two gene families has
become clearer with the availability of Aldh2−/− and Fancd2−/− knockout mice that develop
leukemia both with and without ethanol exposure due to the inability to metabolize
acetaldehyde and repair the associated DNA lesions [144]. Further studies using aged
Aldh2−/− Fancd2−/− mice that did not develop leukemia showed that the mice are
predisposed to developing aplastic anemia due to the accumulation of DNA damage within
the hematopoietic stem and progenitor cell pool [145]. This relationship has been further
explored in humans by increased bone marrow failure in Fanconi Anemia patients who have
the defective ALDH2 gene variant [146]. Similar animal models are being developed and
utilized to examine comparable susceptibilities to endogenous and exogenous formaldehyde.
A current review on Fanconi Anemia has examined possible mechanisms for the
susceptibility to endogenous aldehydes [147]. What has not been recognized is that bone
marrow of nonhuman primates has ~ 5 times higher endogenous formaldehyde N2-HOMe-
dG adducts than other tissues [94]. At this time, no data are available to compare this with
human bone marrow. If present in humans, it could represent an endogenous pathway that
increases the susceptibility of bone marrow toxicity in Fanconi Anemia patients.
What is clear, is that endogenous DNA damage is associated with disease. However,
controlling diseases arising from the Endogenous Exposome will certainly be a challenge.
Nevertheless, using data such as the research presented in this review has major implications
for mutagenesis, cancer and science-based risk assessment. It has long been known that
mutations do not go to zero at very low exposures, yet the default science policy for
genotoxic chemicals is currently to linearly extrapolate risks down to 1 additional cancer in
a million individuals. Such risks have never been demonstrated in humans or animals. It is
well recognized that mutations represent major key events in carcinogenesis. As such,
mutations represent critical information for carcinogenic risks.
The research conducted by Moeller, et al. on acetaldehyde provides the clearest evidence
that endogenous DNA adducts can have major effects on the total formation of both
endogenous and exogenous DNA adducts. It also demonstrates the effect of endogenous
DNA adducts on the induction of mutations and demonstrates that low exogenous exposures
do not increase mutations [133]. Figure 4 clearly shows the contribution of endogenous
(black) and exogenous N2-ethylidene-dG adducts (red). Our biostatisticians were asked
when does the total adduct load of both endogenous and exogenous adducts become
significantly greater than endogenous adducts alone. As discussed earlier, it was only at 50
μM [13C2]-acetaldehyde and higher that the exposures increased the total DNA adducts. Of
even greater importance, micronuclei and cell death were not increased over background
until the cells were exposed to 1000 μM [13C2]-acetaldehyde [133]. Likewise, the studies of
Aldh2−/− and Fancd2−/− knockout mice clearly demonstrate that endogenous aldehyde
exposure induces bone marrow toxicity and leukemia, with no exogenous exposure.
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As more and more studies show thresholds for mutagenesis and a greater understanding of
why such thresholds are present, defaults should be replaced with scientific data when it is
available. This review has certainly demonstrated that many forms of endogenous DNA
damage are present in the cells of our bodies. The data in Table 1 represent our results over
the past two decades, but additional forms of endogenous DNA damage are known [140,
141, 148, 149]. Penman and Crespi published one of the seminal papers on background
mutations in untreated human cells [150]. They evaluated TK mutations in 87 independent
studies and hprt mutations in 34 independent studies and found that mutations ranged from
1–4 mutations per 106 cells. These background mutations can arise from the Endogenous
Exposome, as well as errors of DNA polymerases.
Acknowledgments
The authors acknowledge the expertise and dedication of Ms. Hadley Hartwell for her assistance in formatting and
preparing this manuscript.
The research conducted by the authors was supported in part by grants from the NIEHS Superfund Basic Research
Program (P42-ES 5948), the NIEHS Center for Environmental Health and Susceptibility (P30 ES 10126) and the
Texas Commission for Environmental Quality (582-12-21861).
Reference List
1. Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of
environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers
Prev. 2005; 14:1847–1850. [PubMed: 16103423]
2. Liory P, Rappaport S. Exposure science and the exposome: an opportunity for coherence in the
environmental health sciences. Environ Health Perspect. 2011; 119:A466–A467. [PubMed:
22171373]
3. Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012; 41:24–32. [PubMed:
22296988]
4. Lindahl T, Andersson A. Rate of chain breakage at apurinic sites in double-stranded
deoxyribonucleic acid. Biochemistry (Mosc). 1972; 11:3618–3623.
5. Nakamura J, Walker VE, Upton PB, Chiang SY, Kow YW, Swenberg JA. Highly sensitive apurinic/
apyrimidinic site assay can detect spontaneous and chemically induced depurination under
physiological conditions. Cancer Res. 1998; 58:222–225. [PubMed: 9443396]
6. Branco MR, Ficz G, Reik W. Uncovering the role of 5-hydroxymethylcytosine in the epigenome.
Nat Rev Genet. 2012; 13:7–13. [PubMed: 22083101]
7. Muramatsu, M.; Nagaoka, H.; Shinkura, R.; Begum, NA.; Honjo, T. Discovery of Activation
Induced Cytidine Deaminase, the Engraver of Antibody Memory. In: Frederick, WAaT, editor.
Advances in Immunology, AID for Immunoglobulin Diversity. Academic Press; 2007. p. 1-36.
8. Friedberg, EC.; Walker, GC.; Siede, W.; Wood, RD.; Schultz, R.; Ellenberger, T. DNA Repair and
Mutagenesis. ASM Press; Washington, DC: 2005.
9. Swenberg JA, Lu K, Moeller BC, Gao L, Upton PB, Nakamura J, Starr TB. Endogenous versus
exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment. Toxicol
Sci. 2011; 120(Suppl 1):S130–S145. [PubMed: 21163908]
10. Nakamura J, La DK, Swenberg JA. 5′-Nicked apurinic/apyrimidinic sites are resistant to β-
elimination by β-polymerase and are persistent in human cultured cells after oxidative stress. J
Biol Chem. 2000; 275:5323–5328. [PubMed: 10681505]
11. Rai P, Cole TD, Wemmer DE, Linn S. Localization of Fe2+ at an RTGR sequence within a DNA
duplex explains preferential cleavage by Fe2+ and H2O2. Journal of Molecular Biology. 2001;
312:1089–1101. [PubMed: 11580252]
12. Burrows CJ, Muller JG. Oxidative Nucleobase Modifications Leading to Strand Scission. Chem
Rev. 1998; 98:1109–1152. [PubMed: 11848927]
Nakamura et al. Page 14






















13. Pogozelski WK, Tullius TD. Oxidative strand scission of nucleic acids: Routes initiated by
hydrogen abstraction from the sugar moiety. Chemical Review. 1998; 98:1089–1107.
14. Nakamura J, Gul H, Tian X, Bultman SJ, Swenberg JA. Detection of PIGO-deficient cells using
proaerolysin: a valuable tool to investigate mechanisms of mutagenesis in the DT40 cell system.
PLoS One. 2012; 7:e33563. [PubMed: 22428069]
15. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class Switch
Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a
Potential RNA Editing Enzyme. Cell. 2000; 102:553–563. [PubMed: 11007474]
16. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-
Lagelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M,
Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A. Activation-Induced Cytidine
Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome
(HIGM2). Cell. 2000; 102:565–575. [PubMed: 11007475]
17. Shimizu T, Marusawa H, Endo Y, Chiba T. Inflammation-mediated genomic instability: roles of
activation-induced cytidine deaminase in carcinogenesis. Cancer Sci. 2012; 103:1201–1206.
[PubMed: 22469133]
18. Guo J, Su Y, Zhong C, Ming Gl, Song H. Hydroxylation of 5-Methylcytosine by TET1 Promotes
Active DNA Demethylation in the Adult Brain. Cell. 2011; 145:423–434. [PubMed: 21496894]
19. Amente S, Bertoni A, Morano A, Lania L, Avvedimento EV, Majello B. LSD1-mediated
demethylation of histone H3 lysine 4 triggers Myc-induced transcription. Oncogene. 2010;
29:3691–3702. [PubMed: 20418916]
20. Perillo B, Ombra MN, Bertoni A, Cuozzo C, Sacchetti S, Sasso A, Chiariotti L, Malorni A,
Abbondanza C, Avvedimento EV. DNA Oxidation as Triggered by H3K9me2 Demethylation
Drives Estrogen-Induced Gene Expression. Science. 2008; 319:202–206. [PubMed: 18187655]
21. Nakamura J, Purvis ER, Swenberg JA. Micromolar concentrations of hydrogen peroxide induce
oxidative DNA lesions more efficiently than millimolar concentrations in mammalian cells.
Nucleic Acids Res. 2003; 31:1790–1795. [PubMed: 12626721]
22. Boysen G, Collins LB, Liao S, Luke AM, Pachkowski BF, Watters JL, Swenberg JA. Analysis of
8-oxo-7,8-dihydro-2′-deoxyguanosine by ultra high pressure liquid chromatography-heat assisted
electrospray ionization-tandem mass spectrometry. J Chromatog B. 2010; 878:375–380.
23. Thomas AD, Jenkins GJS, Kaina B, Bodger OG, Tomaszowski KH, Lewis PD, Doak SH, Johnson
GE. Influence of DNA Repair on Nonlinear Dose-Responses for Mutation. Toxicol Sci. 2013;
132:87–95. [PubMed: 23288051]
24. Maltoni C, Lodi P. Results of suptum, cytology among workers exposed to vinyl chloride and to
poly(vinyl chloride). Environ Health Perspect. 1981; 41:85–88. [PubMed: 7333246]
25. Creech JL Jr, Johnson MN. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J
Occup Med. 1974; 16:150–151. [PubMed: 4856325]
26. Block JB. Angiosarcoma of the liver following vinyl chloride exposure. J Am Med Assoc. 1974;
229:53–54.
27. Lee FI, Smith PM, Bennett B, Williams DMJ. Occupationally related angiosarcoma of the liver in
the United Kingdom 1972–1994. Gut. 1996; 39:312–318. [PubMed: 8977349]
28. Lee FI, Harry DS. Angiosarcoma of the liver in a vinyl-chloride worker. The Lancet. 1974;
303:1316–1318.
29. Maltoni C, Cotti G. Carcinogenicity of vinyl chloride in Sprague-Dawley rats after prenatal and
postnatal exposure. Ann N Y Acad Sci. 1988; 534:145–159. [PubMed: 3389652]
30. Smith LR, Dragun J. Degradation of volatile chlorinated aliphatic priority pollutants in
groundwater. Envrion Int. 1984; 10:291–298.
31. Kielhorn J, Melber C, Wahnschaffe U, Aitio A, Mangelsdorf I. Vinyl chloride: Still a cause for
concern. Environ Health Perspect. 2000; 108:579–588. [PubMed: 10905993]
32. Mersiowsky I, Weller M, Ejlertsson J. Fate of plasticised PVC products under landfill conditions: a
laboratory-scale landfill simulation reactor study. Water Res. 2001; 35:3063–3070. [PubMed:
11487101]
Nakamura et al. Page 15






















33. Hata J, Takamizawa K, Miyata N, Iwahori K. Biodegradation of cis-1,2-dichloroethylene and vinyl
chloride in anaerobic cultures enriched from landfill leachate sediment under Fe(III)-reducing
donditions. Biodegradation. 2003; 14:275–283. [PubMed: 12948057]
34. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for vinyl
chloride, potential for human exposure. US Department of Health and Human Services; 2006. p.
169-196.
35. Bartsch H, Montesano R. Mutagenic and carcinogenic effects of vinyl chloride. Mutat Res. 1975;
32:93–114. [PubMed: 765794]
36. Loprieno N, Barale R, Baroncelli S, Bartsch H, Bronzetti G, Cammelini A, Corsi C, Frezza D,
Nieri R, Leporini C, Rosellini D, Rossi AM. Induction of gene mutations and gene conversions by
vinyl chloride metabolites in yeast. Cancer Res. 1977; 37:253–257. [PubMed: 318606]
37. Loprieno N, Barale R, Baroncelli S, Bauer C, Bronzetti G, Cammellini A, Cercignani G, Corsi C,
Gervasi G, Leporini C, Nieri R, Rossi AM, Stretti G, Turchi G. Evaluation of the genetic effects
induced by vinyl chloride monomer (VCM) under mammalian metabolic activation: studies in
vitro and in vivo. Mutat Res. 1976; 40:85–96. [PubMed: 778611]
38. Bolt HM. Metabolic activation of vinyl chloride, formation of nucleic acid adducts and relevance
to carcinogenesis. IARC Sci Publ. 1986:261–268. [PubMed: 3793177]
39. Barbin A, Laib RJ, Bartsch H. Lack of miscoding properties of 7-(2-oxoethyl)guanine, the major
vinyl chloride-DNA adduct. Cancer Res. 1985; 45:2440–2444. [PubMed: 3986785]
40. Cheng KC, Preston BD, Cahill DS, Dosanjh MK, Singer B, Loeb LA. The vinyl chloride DNA
derivative N2,3-ethenoguanine produces G-->A transitions in Escherichia coli. Proc Natl Acad Sci
USA. 1991; 88:9974–9978. [PubMed: 1946466]
41. Singer B, Essigmann JM. Site-specific mutagenesis: retrospective and prospective. Carcinogenesis.
1991; 12:949–955. [PubMed: 2044201]
42. Simha D, Palejwala VA, Humayun MZ. Mechanisms of mutagenesis by exocyclic DNA adducts.
Construction and in vitro template characteristics of an oligonucleotide bearing a single site-
specific ethenocytosine. Biochemistry (Mosc). 1991; 30:8727–8735.
43. Chaudhary AK, Nokubo M, Reddy GR, Yeola SN, Morrow JD, Blair IA, Marnett LJ. Detection of
endogenous malondialdehyde-deoxyguanosine adducts in human liver. Science. 1994; 265:1580–
1582. [PubMed: 8079172]
44. Nair J, Barbin A, Guichard Y, Bartsch H. 1,N6-Ethenodeoxyadenosine and 3,N4-
ethenodeoxycytidine in liver DNA from humans and untreated rodents detected by
immunoaffinity/32P-postlabeling. Carcinogenesis. 1995; 16:613–617. [PubMed: 7697821]
45. Morinello EJ, Ham AJL, Ranasinghe A, Nakamura J, Upton PB, Swenberg JA. Molecular
dosimetry and repair of N2,3-ethenoguanine in rats exposed to vinyl chloride. Cancer Res. 2002;
62:5189–5195. [PubMed: 12234983]
46. Mitro KL, Scheller NA, Ranasinghe A, Swenberg JA. Quantitation of endogenous N2,3-
ethenoguanine in human and rat liver DNA using high resolution mass spectrometry. Proc Am
Assoc Cancer Res. 1995; 36:142.
47. Nair J, Vaca CE, Velic I, Mutanen M, Valsta LM, Bartsch H. High dietary ω-6 polyunsaturated
fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of
female subjects. Cancer Epidemiol Biomarkers Prev. 1997; 6:597–601. [PubMed: 9264272]
48. Morinello EJ, Ham AJL, Ranasinghe A, Sangaiah R, Swenberg JA. Simultaneous quantitation of
N2,3-ethenoguanine and 1,N2-ethenoguanine with an immunoaffinity/gas chromatography/high-
resolution mass spectrometry assay. Chem Res Toxicol. 2001; 14:327–334. [PubMed: 11258983]
49. Ham AJL, Ranasinghe A, Morinello EJ, Nakamura J, Upton PB, Johnson F, Swenberg JA.
Immunoaffinity/gas chromatography/high-resolution mass spectrometry method for the detection
of N2,3-ethenoguanine. Chem Res Toxicol. 1999; 12:1240–1246. [PubMed: 10604874]
50. Mutlu E, Jeong YC, Collins LB, Ham AJL, Upton PB, Hatch G, Winsett D, Evansky P, Swenberg
JA. A new LC-MS/MS method for the quantification of endogenous and vinyl chloride-induced 7-
(2-oxoethyl)guanine in Sprague–Dawley rats. Chem Res Toxicol. 2012; 25:391–399. [PubMed:
22211352]
Nakamura et al. Page 16






















51. Bartsch H, Nair J. Potential role of lipid peroxidation derived DNA damage in human colon
carcinogenesis: studies on exocyclic base adducts as stable oxidative stress markers. Cancer Detect
Prev. 2002; 26:308–312. [PubMed: 12430635]
52. De Bont R, van Larebeke N. Endogenous DNA damage in humans: A review of quantitative data.
Mutagenesis. 2004; 19:169–185. [PubMed: 15123782]
53. Frank A, Seitz HK, Bartsch H, Frank N, Nair J. Immunohistochemical detection of 1,N6-
ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-
carcinogenesis. Carcinogenesis. 2004; 25:1027–1031. [PubMed: 14742317]
54. Sodum RS, Chung FL. Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-
hydroxynonanal. Cancer Res. 1991; 51:137–143. [PubMed: 1703030]
55. Guichard Y, el Ghissassi F, Nair J, Bartsch H, Barbin A. Formation and accumulation of DNA
ethenobases in adult Sprague-Dawley rats exposed to vinyl chloride. Carcinogenesis. 1996;
17:1553–1559. [PubMed: 8761409]
56. Ham AJ, Engelward BP, Koc H, Sangaiah R, Meira LB, Samson LD, Swenberg JA. New
immunoaffinity-LC-MS/MS methodology reveals that Aag null mice are deficient in their ability
to clear 1,N6-etheno-deoxyadenosine DNA lesions from lung and liver in vivo. DNA Repair. 2004;
3:257–265. [PubMed: 15177041]
57. Fedtke N, Walker VE, Swenberg JA. Determination of 7-(2-oxoethyl)guanine and N2,3-
ethenoguanine in DNA hydrolysates by HPLC. Arch Toxicol Supp. 1989; 13:214–218.
58. Fedtke N, Boucheron JA, Turner MJ, Swenberg JA. Vinyl chloride-induced DNA adducts. I:
Quantitative determination of N2,3-ethenoguanine based on electrophore labeling. Carcinogenesis.
1990; 11:1279–1285. [PubMed: 2387013]
59. Fedtke N, Boucheron JA, Walker VE, Swenberg JA. Vinyl chloride-induced DNA adducts. II:
Formation and persistence of 7-(2′-oxoethyl)guanine and N2,3-ethenoguanine in rat tissue DNA.
Carcinogenesis. 1990; 11:1287–1292. [PubMed: 2387014]
60. Swenberg JA, Fedtke N, Çiroussel F, Barbin A, Bartsch H. Etheno adducts formed in DNA of
vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesis. 1992; 13:727–729.
[PubMed: 1576725]
61. Morinello EJ, Koc H, Ranasinghe A, Swenberg JA. Differential induction of N2,3-ethenoguanine
in rat brain and liver after exposure to vinyl chloride. Cancer Res. 2002; 62:5183–5188. [PubMed:
12234982]
62. Mutlu E, Collins LB, Stout MD, Upton PB, Daye LR, Winsett D, Hatch G, Evansky P, Swenberg
JA. Development and application of an LC-MS/MS method for the detection of the vinyl chloride-
induced DNA adduct N2,3-ethenoguanine in tissues of adult and weanling rats following exposure
to [13C2]-VC. Chem Res Toxicol. 2010; 23:1485–1491. [PubMed: 20799743]
63. IARC monographs on the evaluation of carcinogenic risks to humans. Ethylene Oxide. 2012:379–
400.
64. Marsden DA, Jones DJL, Lamb JH, Tompkins EM, Farmer PB, Brown K. Determination of
endogenous and exogenously derived N7-(2-hydroxyethyl)guanine adducts in ethylene oxide-
treated rats. Chem Res Toxicol. 2007; 20:290–299. [PubMed: 17263564]
65. Törnqvist M, Gustafsson B, Kautiainen A, Harms-Ringdahl M, Granath F, Ehrenberg L.
Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and
ethylene oxide. Carcinogenesis. 1989; 10:39–41. [PubMed: 2910529]
66. Wu K, Chiang S, Shih WC, Huang CCJ, Swenberg JA. The application of mass spectrometry in
molecular dosimetry: Ethylene oxide as an expample. Mass Spectrom Rev. 2011; 30:733–756.
[PubMed: 21328599]
67. Swenberg JA, Fryar-Tita E, Jeong YC, Boysen G, Starr T, Walker VE, Albertini RJ. Biomarkers in
toxicology and risk assessment: informing critical dose-response relationships. Chem Res Toxicol.
2008; 21:253–265. [PubMed: 18161944]
68. IARC monographs on the evaluation of carcinogenic risks to humans. Isoprene. 1994:215–232.
69. Begemann P, Christova-Georgieva NI, Sangaiah R, Koc H, Zhang D, Golding BT, Gold A,
Swenberg JA. Synthesis, characterization, and identification of N7-guanine adducts of isoprene
monoepoxides in vitro. Chem Res Toxicol. 2004; 17:929–936. [PubMed: 15257618]
Nakamura et al. Page 17






















70. Begemann P, Boysen G, Georgieva NI, Sangaiah R, Koshlap KM, Koc H, Zhang D, Golding BT,
Gold A, Swenberg JA. Identification and Characterization of 2′-Deoxyadenosine Adducts Formed
by Isoprene Monoepoxides in Vitro. Chem Res Toxicol. 2011; 24:1048–1061. [PubMed:
21548641]
71. Rice JM, Boffetta P. 1,3-Butadiene, isoprene and chloroprene: Reviews by the IARC monographs
programme, outstanding issues, and research priorities in epidemiology. Chem -Biol Interact.
2001; 135–136:11–26.
72. Groth P, Ausl+ñnder S, Majumder MM, Schultz N, Johansson F, Petermann E, Helleday T.
Methylated DNA Causes a Physical Block to Replication Forks Independently of Damage
Signalling, O6-Methylguanine or DNA Single-Strand Breaks and Results in DNA Damage. J Mol
Biol. 2010; 402:70–82. [PubMed: 20643142]
73. Drabløs F, Feyzi E, Aas PA, Vaagbø CB, Kavli B, Bratlie MS, Peña-Diaz J, Otterlei M, Slupphaug
G, Krokan HE. Alkylation damage in DNA and RNA--repair mechanisms and medical
significance. DNA Repair. 2004; 3:1389–1407. [PubMed: 15380096]
74. Jenkins GJS, Doak SH, Johnson GE, Quick E, Waters EM, Parry JM. Do dose response thresholds
exist for genotoxic alkylating agents? Mutagenesis. 2005; 20:389–398. [PubMed: 16135536]
75. Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional
alkylating agents. Mutat Res. 1990; 231:11–30. [PubMed: 2195323]
76. Gates KS, Nooner T, Dutta S. Biologically relevant chemical reactions of N7-alkylguanine
residues in DNA. Chem Res Toxicol. 2004; 17:839–856. [PubMed: 15257608]
77. Mazon G, Philippin G, Cadet J, Gasparutto D, Modesti M, Fuchs RP. Alkyltransferase-like protein
(eATL) prevents mismatch repair-mediated toxicity induced by O6-alkylguanine adducts in
Escherichia coli. Proceedings of the National Academy of Sciences. 2010; 107:18050–18055.
78. La DK, Swenberg JA. DNA adducts: biological markers of exposure and potential applications to
risk assessment. Mutat Res. 1996; 365:129–146. [PubMed: 8898994]
79. Doak SH, Jenkins GJ, Johnson GE, Quick E, Parry EM, Parry JM. Mechanistic influences for
mutation induction curves after exposure to DNA-reactive carcinogens. Cancer Res. 2007;
67:3904–3911. [PubMed: 17440105]
80. Rydberg B, Lindahl T. Nonenzymatic methylation of DNA by the intracellular methyl group donor
S-adenosyl-L-methionine is a potentially mutagenic reaction. EMBO J. 1982; 1:211–216.
[PubMed: 7188181]
81. Lutz WK. Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis.
Mutat Res. 1990; 238:287–295. [PubMed: 2188125]
82. Lu K, Craft S, Nakamura J, Moeller BC, Swenberg JA. Use of LC-MS/MS and Stable Isotopes to
Differentiate Hydroxymethyl and Methyl DNA Adducts from Formaldehyde and
Nitrosodimethylamine. Chem Res Toxicol. 2012
83. Brink A, Lutz U, Volkel W, Lutz WK. Simultaneous determination of O6-methyl-2′-
deoxyguanosine, 8-oxo-7,8-dihydro-2′-deoxyadenosine in DNA using on-line sample preparatoin
by HPLC column switching coupled to ESI-MS/MS. J Chromatog B. 2006; 830:255–261.
84. Reh BD, DeBord DG, Butler MA, Reid TM, Mueller C, Fajen JM. O6-methylguanine DNA
adducts associated with occupational nitrosamine exposure. Carcinogenesis. 2000; 21:29–33.
[PubMed: 10607730]
85. Georgiadis P, Kaila S, Makedonopoulou P, Fthenou E, Chatzi L, Pletsa V, Kyrtopoulos SA.
Development and Validation of a New, Sensitive Immunochemical Assay for O6-Methylguanine
in DNA and Its Application in a Population Study. Cancer Epidemiology Biomarkers &
Prevention. 2011; 20:82–90.
86. Sharma V, Collins LB, Clement JM, Zhang Z, Nakamura J, Swenberg JA. Molecular dosimetry of
endogenous and exogenous O6-methyl-dG and N7-methyl-G adducts following low dose [D3]-
methylnitrosourea exposures in cultured human cells. Chem Res Toxicol. 2014
87. Doak SH, Br++sehafer K, Dudley E, Quick E, Johnson G, Newton RP, Jenkins GJS. No-observed
effect levels are associated with up-regulation of MGMT following MMS exposure. Mutation
Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2008; 648:9–14.
88. Gocke E. In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2009; 678:101–107.
Nakamura et al. Page 18






















89. Zeiger E, Recio L, Fennell TR, Haseman JK, Snyder RW, Friedman M. Investigation of the low-
dose response in the in vivo induction of micronuclei and adducts by acrylamide. Toxicol Sci.
2008
90. Olipitz W, Wiktor-Brown D, Shuga J, Pang B, McFaline J, Lonkar P, Thomas A, Mutamba J,
Greenberger J, Samson L, Dedon PC, Yanch J, Engelward BP. Integrated Molecular Analysis
Indicates Undetectable Change in DNA Damage in Mice after Continuous Irradiation at ~ 400-
fold Natural Background Radiation. Environ Health Perspect. 2012; 120:1130–1136. [PubMed:
22538203]
91. IARC. Formaldehyde, A review of human carcinogens. Part F: Chemical agents and related
occupations. IARC; Lyon, France: 2012. p. 401-435.
92. IARC. Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. IARC Monogr Eval
Carcinog Risks Hum. 2006; 88:1–287. [PubMed: 17366697]
93. McGhee JD, von Hippel PH. Formaldehyde as a probe of DNA structure. I. Reaction with
exocyclic amino groups of DNA bases. Biochemistry (Mosc). 1975; 14:1281–1296.
94. McGhee JD, von Hippel PH. Formaldehyde as a probe of DNA structure. II. Reaction with
endocyclic imino groups of DNA bases. Biochemistry (Mosc). 1975; 14:1297–1303.
95. McGhee JD, von Hippel PH. Formaldehyde as a probe of DNA structure. 3. Equilibrium
denaturation of DNA and synthetic polynucleotides. Biochemistry (Mosc). 1977; 16:3267–3276.
96. McGhee JD, von Hippel PH. Formaldehyde as a probe of DNA structure. r. Mechanism of the
initial reaction of Formaldehyde with DNA. Biochemistry (Mosc). 1977; 16:3276–3293.
97. Casanova M, Heck H. Further studies of the metabolic incorporation and covalent binding of
inhaled [3H]- and [14C]formaldehyde in Fischer-344 rats: effects of glutathione depletion. Toxicol
Appl Pharmacol. 1987; 89:105–121. [PubMed: 2438809]
98. Heck H, Casanova M. Isotope effects and their implications for the covalent binding of inhaled
[3H]- and [14C]formaldehyde in the rat nasal mucosa. Toxicol Appl Pharmacol. 1987; 89:122–
134. [PubMed: 3590184]
99. Merk O, Speit G. Significance of formaldehyde-induced DNA-protein crosslinks for mutagenesis.
Environ Mol Mutagen. 1998; 32:260–268. [PubMed: 9814441]
100. Merk O, Speit G. Detection of crosslinks with the comet assay in relationship to genotoxicity and
cytotoxicity. Environ Mol Mutagen. 1999; 33:167–172. [PubMed: 10217071]
101. Quievryn G, Zhitkovich A. Loss of DNA-protein crosslinks from formaldehyde-exposed cells
occurs through spontaneous hydrolysis and an active repair process linked to proteosome
function. Carcinogenesis. 2000; 21:1573–1580. [PubMed: 10910961]
102. Solomon MJ, Varshavsky A. Formaldehyde-mediated DNA-protein crosslinking: a probe for in
vivo chromatin structures. Proc Natl Acad Sci U S A. 1985; 82:6470–6474. [PubMed: 2995966]
103. Solomon MJ, Larsen PL, Varshavsky A. Mapping protein-DNA interactions in vivo with
formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell. 1988;
53:937–947. [PubMed: 2454748]
104. Lu K, Ye W, Gold A, Ball LM, Swenberg JA. Formation of S-[1-(N2-
deoxyguanosinyl)methyl]glutathione between glutathione and DNA induced by formaldehyde. J
Am Chem Soc. 2009; 131:3414–3415. [PubMed: 19239220]
105. Lu K, Collins LB, Ru H, Bermudez E, Swenberg JA. Distribution of DNA adducts caused by
inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. Toxicol
Sci. 2010; 116:441–451. [PubMed: 20176625]
106. Lu K, Moeller B, Doyle-Eisele M, McDonald J, Swenberg JA. Molecular dosimetry of N2-
hydroxymethyl-dG DNA adducts in rats exposed to formaldehyde. Chem Res Toxicol. 2011;
24:159–161. [PubMed: 21155545]
107. Moeller BC, Lu K, Doyle-Eisele M, McDonald J, Gigliotti A, Swenberg JA. Determination of
N2-hydroxymethyl-dG Adducts in Nasal Epithelium and Bone Marrow of Non-human Primates
following 13CD2-Formaldehyde Inhalation Exposure. Chem Res Toxicol. 2011; 24:162–164.
[PubMed: 21222454]
108. Lu K, Gul H, Upton PB, Moeller BC, Swenberg JA. Formation of Hydroxymethyl DNA Adducts
in Rats Orally Exposed to Stable Isotope Labeled Methanol. Toxicol Sci. 2011
Nakamura et al. Page 19






















109. Casanova-Schmitz M, Heck HD. Effects of formaldehyde exposure on the extractability of DNA
from proteins in the rat nasal mucosa. Toxicol Appl Pharmacol. 1983; 70:121–132. [PubMed:
6193611]
110. Casanova-Schmitz M, Starr TB, Heck HD. Differentiation between metabolic incorporation and
covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by
inhaled [14C]- and [3H]formaldehyde. Toxicol Appl Pharmacol. 1984; 76:26–44. [PubMed:
6207627]
111. Heck, Hd; Casanova, M.; Steinhagen, WH.; Everitt, JI.; Morgan, KT.; Popp, JA. Formaldehyde
toxicity: DNA–protein cross-linking studies in rats and nonhuman primates. In: Feron, VJ.;
Bosland, MC., editors. Nasal Carcinogenesis in Rodents: Relevance to Human Health Risk.
Wageningen: 1989. p. 159-164.
112. Edrissi B, Taghizadeh K, Moeller BC, Kracko D, Doyle-Eisele M, Swenberg JA, Dedon PC.
Dosimetry of N(6)-formyllysine adducts following [(1)(3)C(2)H(2)]-formaldehyde exposures in
rats. Chem Res Toxicol. 2013; 26:1421–1423. [PubMed: 24087891]
113. Grafstrom RC, Fornace A, Harris CC. Repair of DNA Damage Caused by Formaldehyde in
Human Cells. Cancer Res. 1984; 44:4323–4327. [PubMed: 6467194]
114. Craft TR, Bermudez E, Skopek TR. Formaldehyde mutagenesis and formation of DNA-protein
crosslinks in human lymphoblasts in vitro. Mutat Res. 1987; 176:147–155. [PubMed: 3796657]
115. Shoulkamy MI, Nakano T, Ohshima M, Hirayama R, Uzawa A, Furusawa Y, Ide H. Detection of
DNA-protein crosslinks (DPCs) by novel direct fluorescence labeling methods: distinct stabilities
of aldehyde and radiation-induced DPCs. Nucleic Acids Res. 2012; 40:e143. [PubMed:
22730301]
116. Casanova M, Morgan KT, Gross EA, Moss OR, Heck HA. DNA-protein cross-links and cell
replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde.
Fundam Appl Toxicol. 1994; 23:525–536. [PubMed: 7867904]
117. Zhitkovich A, Costa M. A simple, sensitive assay to detect DNA-protein crosslinks in intact cells
and in vivo. Carcinogenesis. 1992; 13:1485–1489. [PubMed: 1499101]
118. Zhong W, Hee SQ. Quantitation of normal and formaldehyde-modified deoxynucleosides by
high-performance liquid chromatography/UV detection. Biomed Chromatogr. 2004; 18:462–469.
[PubMed: 15340972]
119. Zhong W, Que Hee SS. Formaldehyde-induced DNA adducts as biomarkers of in vitro human
nasal epithelial cell exposure to formaldehyde. Mutat Res. 2004; 563:13–24. [PubMed:
15324745]
120. Zhong W, Hee SSQ. Comparison of UV, fluorescence, and electrochemical detectors for the
analysis of formaldehyde-induced DNA adducts. J Anal Toxicol. 2005; 29:182–187. [PubMed:
15842761]
121. Lu K, Ye W, Zhou L, Collins LB, Chen X, Gold A, Ball LM, Swenberg JA. Structural
characterization of formaldehyde-induced cross-links between amino acids and deoxynucleosides
and their oligomers. J Am Chem Soc. 2010; 132:3388–3399. [PubMed: 20178313]
122. Swenberg JA, Moeller BC, Lu K, Rager JE, Fry RC, Starr TB. Formaldehyde Carcinogenicity
Research: 30 Years and Counting for Mode of Action, Epidemiology, and Cancer Risk
Assessment. Toxicol Pathol. 2013; 41:181–189. [PubMed: 23160431]
123. Committee to Review EPA’s Draft IRIS Assessment of Formaldehyde, R.C. National. Review of
the Environmental Protection Agency’s Draft IRIS Assessment of Formaldehyde. The National
Academies Press; 2011.
124. National Toxicology Program. Report on Carcinogens. 12. U.S. Department of Health and
Human Services, Public Health Service, National Toxicology Program; Washington, DC: 2011.
125. IARC monographs on the evaluation of carcinogenic risks to humans. Alcohol consumption and
ethyl carbanate. 2010
126. Hazen SL, Hsu FF, d’Avignon A, Heinecke JW. Human neutrophils employ myeloperoxidase to
convert alpha-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation
at sites of inflammation. Biochemistry. 1998; 37:6864–6873. [PubMed: 9578573]
Nakamura et al. Page 20






















127. O’Brien PJ, Siraki AG, Shangari N. Aldehyde sources, metabolism, molecular toxicity
mechanisms, and possible effects on human health. Critical Reviews in Toxicology. 2005;
35:609–662. [PubMed: 16417045]
128. Shin HW, Umber BJ, Meinardi S, Leu SY, Zaldivar F, Blake DR, Cooper DM. Acetaldehyde and
hexanaldehyde from cultured white cells. J Transl Med. 2009; 7:31. [PubMed: 19402909]
129. IARC. Alcohol consumption and ethyl carbanate. Monographs on the evaluation of carcinogenic
risks to humans. 2010
130. Albertini RJ. Vinyl acetate monomer (VAM) genotoxicity profile: Relevance for carcinogenicity.
Crit Rev Toxicol. 2013; 43:671–706. [PubMed: 23985073]
131. Hecht SS, McIntee EJ, Wang M. New DNA adducts of crotonaldehyde and acetaldehyde.
Toxicology. 2001; 166:31–36. [PubMed: 11518608]
132. Garcia CC, Angeli JP, Freitas FP, Gomes OF, de Oliveira TF, Loureiro AP, Di MP, Medeiros
MH. [13C2]-Acetaldehyde promotes unequivocal formation of 1,N2-propano-2′-deoxyguanosine
in human cells. J Am Chem Soc. 2011; 133:9140–9143. [PubMed: 21604744]
133. Moeller BC, Recio L, Green A, Sun W, Wright FA, Bodnar WM, Swenberg JA. Biomarkers of
Exposure and Effect in Human Lymphoblastoid TK6 Cells Following [13C2]-Acetaldehyde
Exposure. Toxicol Sci. 2013; 133:1–12. [PubMed: 23425604]
134. Yang IY, Chan G, Miller H, Huang Y, Torres MC, Johnson F, Moriya M. Mutagenesis by
Acrolein-Derived Propanodeoxyguanosine Adducts in Human Cells. Biochemistry (Mosc). 2002;
41:13826–13832.
135. Choi JY, Zang H, Angel KC, Kozekov ID, Goodenough AK, Rizzo CJ, Guengerich FP.
Translesion synthesis across 1,N2-ethenoguanine by human DNA polymerases. Chem Res
Toxicol. 2006; 19:879–886. [PubMed: 16780368]
136. Brooks PJ, Zakhari S. Acetaldehyde and the genome: Beyond nuclear DNA adducts and
carcinogenesis. Environ Molec Mutag. 2013:n/a.
137. Budinsky R, Gollapudi B, Albertini RJ, Valentine R, Stavanja M, Teeguarden J, Fensterheim R,
Rick D, Lardie T, McFadden L, Green A, Recio L. Nonlinear responses for chromosome and
gene level effects induced by vinyl acetate monomer and its metabolite, acetaldehyde in TK6
cells. Environ Molec Mutag. 2013; 54:755–768.
138. Mangerich A, Knutson CG, Parry NM, Muthupalani S, Ye W, Prestwich E, Cui L, McFaline JL,
Mobley M, Ge Z, Taghizadeh K, Wishnok JS, Wogan GN, Fox JG, Tannenbaum SR, Dedon PC.
Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response
and DNA damage leading to colon cancer. Proceedings of the National Academy of Sciences.
2012; 109:E1820–E1829.
139. Nair J, Sinitsina O, Vasunina EA, Nevinsky GA, Laval J, Bartsch H. Age-dependent increase of
etheno-DNA-adducts in liver and brain of ROS overproducing OXYS rats. Biochem Biophys
Res Commun. 2005; 336:478–482. [PubMed: 16137653]
140. Bartsch H, Arab KNJ. Biomarkers for hazard identification in humans. Environmental Health.
2011; 10
141. Nair J, Srivatanakul P, Haas C, Jedpiyawongse A, Khuhaprema T, Seitz HK, Bartsch H. High
urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver
diseases. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2010;
683:23–28.
142. Nair J, De Flora S, Izzotti A, Bartsch H. Lipid peroxidation-derived etheno-DNA adducts in
human atherosclerotic lesions. Mutat Res. 2007; 621:95–105. [PubMed: 17412369]
143. Ridpath JR, Takeda S, Swenberg JA, Nakamura J. Convenient, multi-well plate-based DNA
damage response analysis using DT40 mutants is applicable to high-throughput genotoxicity
assay with characterization of modes of action. Environ Mol Mutagen. 2011; 52:153–160.
[PubMed: 20839229]
144. Langevin F, Crossan GP, Rosado IV, Arends MJ, Patel KJ. Fancd2 counteracts the toxic effects
of naturally produced aldehydes in mice. Nature. 2011; 475:53–58. [PubMed: 21734703]
145. Garaycoechea JI, Crossan GP, Langevin F, Daly M, Arends MJ, Patel KJ. Genotoxic
consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature.
2012; 489:571–575. [PubMed: 22922648]
Nakamura et al. Page 21






















146. Hira A, Yabe H, Yoshida K, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Nakamura J,
Kojima S, Ogawa S, Matsuo K, Takata M, Yabe M. Variant ALDH2 is associated with
accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. Blood.
2013; 122:3206–3209. [PubMed: 24037726]
147. Garaycoechea JI, Patel KJ. Why does the bone marrow fail in Fanconi anemia? Blood. 2014;
123:26–34. [PubMed: 24200684]
148. Nair U, Bartsch H, Nair J. Lipid peroxidation-induced DNA damage in cancer-prone
inflammatory diseases: A review of published adduct types and levels in humans. Free Rad Biol
Med. 2007; 43:1109–1120. [PubMed: 17854706]
149. Swenberg JA, Fedtke N, Ciroussel F, Barbin A, Bartsch H. Etheno adducts formed in DNA of
vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesis. 1992; 13:727–729.
[PubMed: 1576725]
150. Penman BW, Crespi CL. Analysis of human lymphoblast mutation assays by using historical
negative control data bases. Environ Molec Mutag. 1987; 10:35–60.
Nakamura et al. Page 22























Dose-response relationships of H2O2 (30 min exposure) in TK6 cells with respect to (A) 8-
oxodG adducts (B) Mutation frequency (MF) in TK forward mutation assay (MF). Data
represent Mean +/− SD * p<0.05; one-way analysis of variance (ANOVA) with Dunnet’s
test were employed to test for doses statistically significant from control.
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Endogenous versus exogenous adducts in AHH-1 cells exposed to [D3]-Methylnitrosourea
(0.0075uM to 2.5uM) for 1h. The endogenous and exogenous O6-me-dG and N7-me-G
adducts at each exposure concentration are plotted on a log versus log scale. Exogenous
adducts from samples with no detectable amounts are not shown. Data represent Mean +/−
SD. Statistical comparison between the sum of adducts and the endogenous mean was
conducted using a t-test (*p<0.05) to determine doses when the amount of total adducts
become significantly higher than the identical average endogenous adducts. This dose was ≥
0.75uM for N7-me-G and ≥0.025uM for O6-me-dG.
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Approach for stable isotope versus endogenous N2-HOMedG
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When do exogenous DNA adducts result in a total endogenous plus exogenous adducts that
is significantly greater and mutations are significantly greater than controls. Adapted from
Moeller, et al., Toxicol. Sci. 133: 1–12, 2013
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Table 1
The Endogenous Exposome
Steady-State amounts of Endogenous DNA Damage
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